Magnetic Resonance Imaging Monitoring of Multiple Sclerosis Lesion Evolution

The characteristic feature of multiple sclerosis (MS) pathology is the demyelinated plaque distributed throughout the central nervous system. Although MS is a primary demyelinating disease, acute axonal injury is common in actively demyelinating MS lesions and it is considered one of the major determinants of neurological deficit. Magnetic resonance imaging (MRI) has had a dramatic impact on MS in both the clinical practice and basic science settings. Techniques such as T2‐weighted and gadolinium‐enhanced T1‐weighted MRI are very sensitive in detecting lesions and, thus, increase the level of certainty of MS diagnosis. Conventional MRI has also improved our understanding of the pathogenesis of the disease and has provided objective and reliable measures to monitor the effect of experimental treatments in clinical trials. However, conventional MR‘I does not provide specific information on the heterogeneous pathologic substrate of MS lesions. Advanced MRI techniques, such as magnetization transfer imaging, diffusion tensor imaging, and proton MR spectroscopy, offer the unprecedented ability to observe and quantify pathological changes in lesions and normal‐appearing brain tissue over time. The present review will discuss the major contributions of conventional MRI and quantitative MRI techniques to understand how individual MS lesions evolve.

[1]  G J Barker,et al.  Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. , 1999, Magnetic resonance imaging.

[2]  J. McGowan,et al.  The physical basis of magnetization transfer imaging. , 1999, Neurology.

[3]  G. B. Pike Ph. D.,et al.  Magnetization transfer imaging of multiple sclerosis , 2005, The Italian Journal of Neurological Sciences.

[4]  M. Horsfield,et al.  A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads , 1998, Journal of the Neurological Sciences.

[5]  J. Pekar,et al.  Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance , 1991, Journal of magnetic resonance imaging : JMRI.

[6]  H. Powell,et al.  Pathology of multiple sclerosis. , 1983, Neurologic clinics.

[7]  F. Barkhof,et al.  The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS , 2001, Neurology.

[8]  N. Richert Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes". , 2002, Neurology.

[9]  H F McFarland,et al.  The lesion in multiple sclerosis: clinical, pathological, and magnetic resonance imaging considerations. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[10]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[11]  J. Babb,et al.  Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience. , 2005, Radiology.

[12]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[13]  F Barkhof,et al.  Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.

[14]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[15]  R Stollberger,et al.  Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis , 2000, Magnetic resonance in medicine.

[16]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[17]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.

[18]  S W Atlas,et al.  Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.

[19]  Ponnada A Narayana,et al.  Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[20]  M W Weiner,et al.  A serial study of new MS lesions and the white matter from which they arise , 1998, Neurology.

[21]  P. Calabresi,et al.  Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI , 1997, Neurology.

[22]  J. Caillé,et al.  Early structural changes in acute MS lesions assessed by serial magnetization transfer studies , 1998, Neurology.

[23]  P M Matthews,et al.  In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. , 1999, Brain : a journal of neurology.

[24]  G J Barker,et al.  The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.

[25]  D. Arnold,et al.  Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis , 2002, Journal of Neurology.

[26]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[27]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[28]  J A Maldjian,et al.  Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. , 2000, AJNR. American journal of neuroradiology.

[29]  R. Kikinis,et al.  The evolution of multiple sclerosis lesions on serial MR. , 1995, AJNR. American journal of neuroradiology.

[30]  G. Barker,et al.  Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis , 1999, Neurology.

[31]  W. Hickey Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation , 1991, Brain pathology.

[32]  B E Kendall,et al.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.

[33]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[34]  M Cercignani,et al.  Weekly diffusion-weighted imaging of normal-appearing white matter in MS , 2000, Neurology.

[35]  R I Grossman,et al.  Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. , 1995, AJNR. American journal of neuroradiology.

[36]  G. Comi,et al.  Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.

[37]  P. Basser,et al.  Diffusion tensor MR imaging of the human brain. , 1996, Radiology.

[38]  C. Lucchinetti,et al.  A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions , 2001, Annals of neurology.

[39]  R. Tarducci,et al.  1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a: results of a preliminary study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[40]  O. Ciccarelli,et al.  Magnetic resonance outcome of new enhancing lesions in patients with relapsing‐remitting multiple sclerosis , 1999, European Journal of Neurology.

[41]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[42]  M. Filippi,et al.  Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis , 1996, Neuroradiology.

[43]  J. Frahm,et al.  Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.

[44]  R I Grossman,et al.  Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. , 1996, AJNR. American journal of neuroradiology.

[45]  G. Barker,et al.  Correlation of magnetization transfer ration with clinical disability in multiple sclerosis , 1994, Annals of neurology.

[46]  P. Matthews,et al.  Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.

[47]  H I Goldberg,et al.  Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. , 1988, Radiology.

[48]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[49]  F. Barkhof,et al.  Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.

[50]  R. Grossman,et al.  Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. , 1995, AJNR. American journal of neuroradiology.

[51]  C. Pozzilli,et al.  Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.

[52]  Simon K Warfield,et al.  Diffusion Tensor Magnetic Resonance Imaging in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[53]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[54]  R E Lenkinski,et al.  MR proton spectroscopy in multiple sclerosis. , 1992, AJNR. American journal of neuroradiology.

[55]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.

[56]  F. Barkhof,et al.  Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.

[57]  S. Majumdar,et al.  Magnetization transfer ratio in new MS lesions before and during therapy with IFNβ-1a , 2000, Neurology.

[58]  C. Elster,et al.  Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.